These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34242065)

  • 1. Psychotropic Medication Prescribing for Youth at a Regional Autism Center.
    Gannon S; Abdelrazek A; Keller K; Rockhill C; Kim SJ
    J Child Adolesc Psychopharmacol; 2021 Dec; 31(10):653-658. PubMed ID: 34242065
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder.
    Rast JE; Anderson KA; Roux AM; Shattuck PT
    Acad Pediatr; 2021 Mar; 21(2):272-279. PubMed ID: 32492579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites.
    Jackel C; Shults J; Wiley S; Meinzen-Derr J; Augustyn M; Blum N
    J Dev Behav Pediatr; 2017 Oct; 38(8):584-592. PubMed ID: 28816917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.
    Logan SL; Carpenter L; Leslie RS; Garrett-Mayer E; Hunt KJ; Charles J; Nicholas JS
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):323-36. PubMed ID: 25919445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK.
    Alfageh BH; Man KKC; Besag FMC; Alhawassi TM; Wong ICK; Brauer R
    J Autism Dev Disord; 2020 Feb; 50(2):625-633. PubMed ID: 31724119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
    Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
    Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining psychotropic medication use among youth in the U.S. by race/ethnicity and psychological impairment.
    Cook BL; Carson NJ; Kafali EN; Valentine A; Rueda JD; Coe-Odess S; Busch S
    Gen Hosp Psychiatry; 2017; 45():32-39. PubMed ID: 28274336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autism spectrum disorders and their treatment with psychotropic medications in a nationally representative outpatient sample: 1994-2009.
    Kamimura-Nishimura K; Froehlich T; Chirdkiatgumchai V; Adams R; Fredstrom B; Manning P
    Ann Epidemiol; 2017 Jul; 27(7):448-453.e1. PubMed ID: 28789776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of psychotropic medication in children and adolescents with autism spectrum disorders.
    Coury DL; Anagnostou E; Manning-Courtney P; Reynolds A; Cole L; McCoy R; Whitaker A; Perrin JM
    Pediatrics; 2012 Nov; 130 Suppl 2():S69-76. PubMed ID: 23118256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder.
    Wink LK; Pedapati EV; Adams R; Erickson CA; Pedersen KA; Morrow EM; Kaplan D; Siegel M;
    J Autism Dev Disord; 2018 Nov; 48(11):3711-3719. PubMed ID: 28516426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in Psychotropic Medication Prescription for Adults With Schizophrenia in the United States.
    Bareis N; Olfson M; Wall M; Stroup TS
    Psychiatr Serv; 2022 May; 73(5):492-500. PubMed ID: 34587788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States.
    Esler A; Hewitt A; Hall-Lande J; Pettingell SL; Houseworth J
    J Autism Dev Disord; 2019 Jun; 49(6):2291-2303. PubMed ID: 30706350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data.
    Hong M; Lee SY; Han J; Park JC; Lee YJ; Hwangbo R; Chang H; Cho SW; Bhang SY; Kim B; Hwang JW; Bahn GH
    J Korean Med Sci; 2017 Oct; 32(10):1687-1693. PubMed ID: 28875615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Chart Review of Factors Impacting Psychotropic Prescribing Patterns and Polypharmacy Rates in Youth with Autism Spectrum Disorder during the COVID-19 Pandemic.
    Taniguchi E; Conant K; Keller K; Kim SJ
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Primary Care Providers' Consultations With a Statewide Child Psychiatry Access Program Regarding Autism Spectrum Disorder.
    Reinblatt SP; Coble K; Williams JL; Cotton AM; Bettencourt AF
    J Acad Consult Liaison Psychiatry; 2022; 63(5):463-473. PubMed ID: 35085823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label prescribing of psychotropic drugs in a Danish child and adolescent psychiatric outpatient clinic.
    Nielsen ES; Hellfritzsch M; Sørensen MJ; Rasmussen H; Thomsen PH; Laursen T
    Eur Child Adolesc Psychiatry; 2016 Jan; 25(1):25-31. PubMed ID: 25724547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
    Mittal S; Boan AD; Kral MC; Lally MD; van Bakergem K; Macias MM; LaRosa A
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.